Found 69 All Conditions trials

Below is a list of actively recruiting clinical trials based on your search for "All Conditions"

18 years or above
All genders
Phase 1
Interventional
This study investigates the condition of relapsed/refractory myeloma. It focuses on understanding more about this condition through the use of an investigational medication.The purpose of this study is to evaluate the safety and effectiveness of the investigational medication. It looks at how well participants tolerate the medication and its overall …
18 years or above
Accepts healthy volunteer
Male
Phase 3
This study investigates the use of tadalafil for erectile dysfunction. The purpose of this study is to see if participants can choose and use tadalafil appropriately based on product labeling and a health survey.The study evaluates how well participants can follow instructions for using tadalafil safely and effectively. It looks …
10 years - 65 years
All genders
Phase 3
Interventional
This study investigates sickle-cell disease. It focuses on understanding the effects of an investigational medication in people with this condition.This study evaluates the safety and effectiveness of the investigational medication. The purpose of this study is to gather information on how well the medication works and how safe it is …
12 years or above
All genders
Phase 4
Interventional
This study investigates synovial hypertrophy in individuals with hemophilia A.The study evaluates the effects of a weekly dose of investigational medication over a 12-month period. It focuses on assessing changes in joint conditions related to synovial hypertrophy.Who can participate: Participants must be 12 years or older with moderate to severe …
18 years - 75 years
All genders
Phase 2
Interventional
This study investigates the effects of different doses of an investigational medication compared to a placebo for Crohn's disease.The purpose of this study is to understand the safety and effectiveness of the investigational medication for people with Crohn's disease.Who can participate: Adults with moderate to severe Crohn's disease, who have …
18 years or above
All genders
Phase 3
Interventional
This study investigates immune thrombocytopenia (ITP) in adults who did not respond to first-line treatment. The purpose of this study is to explore the effects of the investigational medication on this condition.The study evaluates the safety and effectiveness of the investigational medication. It looks at how well the medication works …
1 year - 18 years
All genders
Phase 2
Interventional
This study investigates chronic graft versus host disease (cGVHD) in children. The purpose of this study is to evaluate an investigational medication in children who have this condition.The study will assess the safety and effectiveness of the investigational medication in treating cGVHD. Researchers will evaluate how well the medication works …
16 years - 80 years
All genders
Phase 3
Interventional
This study investigates the effects of an investigational medication on individuals with moderately to severely active Crohn's Disease. The study focuses on assessing the safety and effectiveness of the investigational medication in participants. It evaluates how well the medication works and its safety profile in treating this condition.Who can participate: …
16 years - 80 years
All genders
Phase 3
Interventional
This study investigates moderately to severely active Crohn's Disease. The purpose of this study is to explore how the investigational medication affects individuals with this condition.The study evaluates the safety and effectiveness of the investigational medication over a prolonged period. It seeks to understand how participants respond to the treatment.Who …
18 years or above
All genders
Phase 1
Interventional
This study investigates advanced solid tumors.The study evaluates the safety of an investigational medication in participants with solid tumors that are hard to treat or have spread throughout the body.Who can participate: Adults with metastatic or unresectable solid tumors that have relapsed or are refractory to treatment. Participants must have …